Literature DB >> 27634016

Outcomes Following Advanced Wound Care for Diabetic Foot Ulcers: A Canadian Study.

Ivana Roth-Albin1, Safiah H C Mai2, Zeeshan Ahmed3, Ji Cheng4, Karen Choong5, Perry V Mayer6.   

Abstract

OBJECTIVES: Data concerning outcomes of Canadian patients with diabetic foot ulcers (DFUs) are limited. The objectives of this study were to evaluate the healing rates and identify the predictors of poor outcomes following advanced wound care in patients presenting with DFUs.
METHODS: We conducted retrospective cohort study of adult patients who had DFUs and were referred to a single Canadian advanced diabetic foot and wound care centre between January 1, 2010, and December 31, 2010. The primary outcome was the healing rate at 52 weeks. The generalized estimating equation model was used to identify potential risk factors associated with delayed healing of DFUs.
RESULTS: Of the 40 patients for whom there were complete follow ups, 35 (87.5%) had healing of all DFUs by 52 weeks. Predictors of poor healing were the presence of chronic ulcers, ulcer sizes >1 cm2, peripheral vascular disease and multiple ulcers at first presentation. Of the patients, 7.1% required amputation, and 8.9% of patients receiving our treatment died before 52 weeks. At 52 weeks of follow up, 16 of 17 recurrent ulcers and 68 of 108 pre-existing ulcers had healed. Compared to the unadjusted healing rate of preexisting ulcers (63.0%), the unadjusted healing rate of recurrent ulcers (94.1%) was significantly higher (p=0.01).
CONCLUSIONS: Our findings demonstrate that patients with DFUs in Canada who receive early and continued care from specialized, outpatient, advanced wound care centres experience significantly improved rates of healing of recurrent DFUs compared to pre-existing DFUs.
Copyright © 2016 Canadian Diabetes Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  advanced wound care; diabetic foot ulcers; multidisciplinary care; soins des plaies complexes; soins multidisciplinaires; ulcères du pied diabétique

Mesh:

Year:  2016        PMID: 27634016     DOI: 10.1016/j.jcjd.2016.06.007

Source DB:  PubMed          Journal:  Can J Diabetes        ISSN: 1499-2671            Impact factor:   4.190


  6 in total

1.  Regional health care services and rates of lower extremity amputation related to diabetes and peripheral artery disease: an ecological study.

Authors:  Charles de Mestral; Mohamad A Hussain; Peter C Austin; Thomas L Forbes; Atul Sivaswamy; Ahmed Kayssi; Konrad Salata; Harindra C Wijeysundera; Subodh Verma; Mohammed Al-Omran
Journal:  CMAJ Open       Date:  2020-10-27

2.  Outcomes and prognosis of diabetic foot ulcers treated by an interdisciplinary team in Canada.

Authors:  Jérôme Patry; André Tourigny; Marie-Philippe Mercier; Clermont E Dionne
Journal:  Int Wound J       Date:  2020-11-25       Impact factor: 3.315

3.  Annual Direct Medical Costs of Diabetic Foot Disease in Brazil: A Cost of Illness Study.

Authors:  Cristiana M Toscano; Tatiana H Sugita; Michelle Q M Rosa; Hermelinda C Pedrosa; Roger Dos S Rosa; Luciana R Bahia
Journal:  Int J Environ Res Public Health       Date:  2018-01-08       Impact factor: 3.390

4.  Risk of contralateral lower limb amputation and death after initial lower limb amputation - a population-based study.

Authors:  K Huseynova; R Sutradhar; G L Booth; A Huang; J G Ray
Journal:  Heliyon       Date:  2018-10-09

5.  Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers.

Authors:  Andreas Kerstan; Kathrin Dieter; Elke Niebergall-Roth; Markus H Frank; Mark A Kluth; Sabrina Klingele; Michael Jünger; Christoph Hasslacher; Georg Daeschlein; Lutz Stemler; Ulrich Meyer-Pannwitt; Kristin Schubert; Gerhard Klausmann; Titus Raab; Matthias Goebeler; Korinna Kraft; Jasmina Esterlechner; Hannes M Schröder; Samar Sadeghi; Seda Ballikaya; Martin Gasser; Ana M Waaga-Gasser; George F Murphy; Dennis P Orgill; Natasha Y Frank; Christoph Ganss; Karin Scharffetter-Kochanek
Journal:  Stem Cell Res Ther       Date:  2022-09-05       Impact factor: 8.079

6.  Skin Substitutes for Adults With Diabetic Foot Ulcers and Venous Leg Ulcers: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2021-06-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.